Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Portfolio > Alternative Investments > Private Equity

MetLife Starts $1.8 Billion Offering

X
Your article was successfully shared with the contacts you provided.

MetLife Inc. has started selling a large number of “common equity units” in connection with efforts to acquire Travelers Life & Annuity from Citigroup Inc.[@@]

MetLife, New York, hopes to raise $1.8 billion in financing for the deal from the common equity unit sale, and it also hopes to raise $600 million by selling floating-rate preferred stock and $1.5 billion by selling fixed-rate preferred stock.

MetLife has agreed to pay Citigroup, New York, about $11.5 billion in cash and stock for Travelers Life.

Units of Bank of America Corp., Charlotte, N.C., and Goldman Sachs Group Inc., New York, are coordinating the common equity unit offering.

Each unit in the offering “will consist of a fractional interest in trust preferred securities issued by subsidiary trusts of MetLife, as well as a stock purchase contract requiring the holder to purchase, and MetLife to sell, shares of MetLife common stock,” MetLife says in an announcement of the offering.

The number of shares of common stock that unit holders must buy “is to be determined upon settlement of the contract based on the market price of MetLife common stock shortly before the time of settlement,” MetLife says.

Unit holders can separate the interest in the trust preferred securities from the stock purchase contract.

MetLife expects to settle some of the stock purchase contracts about 3 years after it issues the common equity units and the rest about 6 months later, the company says.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.